Increasing Prevalence of Cancer and Cardio Diseases Mainly Driving Demand for Radiopharmaceuticals Market to Exceed $10 billion by 2024 - Market Research Report (2018-2025) by Industry Experts, Inc.
Industry Experts, Inc. unveiled the new global market research report " Global Radiopharmaceuticals Market – Products and Applications ". The report reveals that the North American market is the largest accounts for more than half of the global market in 2018 with an estimated US$3.1 billion. Asia-Pacific is projected the fastest growing region with market growing at a CAGR of about 14% during 2018-2025. Rising prevalence of cancer and cardiovascular diseases are the main factors driving the Radiopharmaceuticals market. Technological advancement, elevated healthcare expenditure, prevalence of chronic ailments, increasing geriatric population, rising awareness of Radiopharmaceuticals applications in disease treatment, poor dietary habits, unhealthy lifestyle and increased awareness about the benefits of targeted alpha therapy are some of the other key factors fueling the Radiopharmaceuticals market. SPECT Radioisotopes constitute the single largest product type in global ...